Improvement of bone formation is necessary for successful treatment of the bone defects associated with osteoporosis. In this study, we sought to elucidate the osteogenic activity of peanut sprouts and their bioactive components. We found that peanut sprout water extract (PSWE) enhanced bone morphogenetic protein-2- Osteoporosis is caused by an imbalance between the activities of bone-forming osteoblasts and bone-resorbing osteoclasts (Takayanagi, 2005) . Accordingly, control of bone formation and/or bone resorption
represents a promising strategy for treatment of bone metabolic disorders such as osteoporosis. In clinical practice, treatment efforts have focused on anti-resorptive agents, but these have not been sufficiently effective. Accordingly, new strategies for inducing osteoblast differentiation are required.
Osteoblast differentiation is a pivotal event in bone formation.
Differentiation of osteoblasts from mesenchymal progenitor cells contributes to bone formation by promoting the production of extracellular matrix, which supports ossification by closely packed sheets on the bone surface (Beloti & Rosa, 2005) . Osteoblast differentiation is regulated by signaling cascades and several transcriptional factors that promote mineralization and formation of bone. Runt-related transcription factor 2 (Runx2), a transcription factor, is essential for osteoblast differentiation via its ability to induce the expression of osteoblastic downstream effectors (Komori, 2011) . Furthermore, Runx2 is a pivotal mediator of signaling molecules including bone morphogenetic proteins, multifunctional growth factors belonging to the transforming growth factor beta superfamily (Chen, Zhao, & Mundy, 2004; Wang et al., 2006) . Accordingly, activation of Runx2 represents a therapeutic strategy for treating osteoporosis with bone defect.
Plant-derived natural products are widely used as complementary and alternative therapies for many diseases, including osteoporosis (Jiang et al., 2015) . A simple and effective tool for improving biological activity is sprouting, which increases the levels of bioactive and nutritional components in seeds. For example, sprouting of peanut increases the abundance of bioactive components including resveratrol, isoflavones, and polyphenols (Kim, Park, & Lim, 2011; Wang et al., 2005) . Furthermore, peanut sprouts have neuroprotective, anti-oxidative, and anti-obesity activities (Kang et al., 2010; Kang, Ha, Woo, & Kim, 2014; Lertkaeo et al., 2017) . However, previous studies have not explored the effects of peanut sprout extract (PSE) on osteogenic differentiation or the molecular mechanisms underlying any such effects.
In this study, we investigated the anabolic activity of PSE and its pharmaceutical components on bone morphogenetic protein-2 (BMP-2)-mediated osteoblast differentiation and optimized the osteogenic effect of peanut sprout water extract (PSWE) by manipulating sprouting time. Investigation of the mode of action revealed that PSWE and soyasaponin Bb, a bioactive component of the extract, potentiated the osteogenic mechanism.
| MATERIALS AND METHODS

| Preparation of peanut sprout extract
Sinpalkwang peanut (Arachis hypogaea L.) seeds were cultivated in 2016 in the experimental field at the National Institute of Crop Science, Jeonbuk, Korea. Peanut seeds were washed, incubated in water at 20°C for 18 hr, and then germinated at 65% humidity at 25°C in the dark. After harvesting 13 days after germination, peanut sprouts were immediately washed with clean sterile water and then freeze dried at −70°C. The dried sprouts (1.0 kg) were extracted with water, prethanol, or hexane (three extractions, 10 L each) in a shaking incubator for 2 days at 40°C. The extracts were filtered and evaporated under a vacuum and subsequently freeze dried to yield 112 g of water extract (11.2%), 85 g of prethanol extract (8.5%), and 45 g of hexane extract (4.5%) as dried powder. The concentrated extract was suspended in water, prethanol, or hexane to a final concentration of 100 mg/ml. The stock solution was further diluted in phosphatebuffered saline (PBS).
| Reagents and antibodies
Recombinant human bone morphogenetic protein-2 (rhBMP-2) was purchased from R&D Systems (Minneapolis, MN, USA). Penicillin, streptomycin, cell culture medium, and fetal bovine serum (FBS) were purchased from Invitrogen Life Technologies (Carlsbad, CA, USA).
Antibodies against the following proteins were purchased from the indicated companies: actin, Smad, and secondary antibodies (Santa Cruz Biotechnology, Dallas, TX, USA); p-Smad, p-AKT, AKT, MAP kinases, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Cell Signaling Technology, Beverly, MA, USA).
| Cell culture
All experiments were performed as described previously (Choi et al., 2017 ) with some modifications. Mouse mesenchymal precursor C2C12 cells were obtained from the American Type Collection (Manassas, VA, USA). C2C12 cells were maintained in alpha minimum essential medium (α-MEM) containing 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. To differentiate C2C12 into osteoblasts, the cells were seeded and allowed to attach and grow for 1 day, after which the medium was replaced with differentiation medium (α-MEM containing 5% FBS and 100 ng/ml rhBMP-2). The medium was changed every 3 days. Osteoblastic bone formation was monitored by alkaline phosphatase (ALP) staining. 
| Cell proliferation assay
C2C12 cells were plated on 96-well plates in triplicate. After treatment with PSE or soyasaponin Bb, the cells were incubated for 3 days and then cell viability was measured using the Cell Counting Kit 8 (CCK-8; Dojindo Molecular Technologies, Rockville, MD, USA).
2.6 | RNA isolation and real-time polymerase chain reaction analysis Primers were chosen using the Primer3 online tool. Primer sets used in this study are shown in Table S1 . Total RNA was extracted from C2C12 cells using Trizol reagent (Invitrogen). First stand cDNA was synthesized using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific). Real-time PCR was performed using Applied Biosystems Power-Up SYBR green PCR master mix (Thermo Scientific) and detected using Quantstudio®5 Real-Time PCR (Thermo Scientific). The gene encoding GAPDH was used as an internal standard. All reactions were performed in triplicate, and data were analyzed using the 2 −ΔΔCt method (Livak & Schmittgen, 2001 50 min, 100% B; 50.1 min, 10% B; held for 9.9 min before returning to the initial conditions. Following injection of 2 μl of sample, eluted soyasaponin Bb was detected using UHPLC-CAD (Corona Veo, Thermo Scientific). The soyasaponin Bb standard was purchased from ChemFaces (Wuhan, China). For isolation, the combined PSWE was evaporated under vacuum to yield a dark green gum (120 g).
The resulting residue was subjected to chromatography on C 18 silica gel (12 × 50 cm, 230-400 mesh, 120 g) using a series of water- 
| UPLC-Q-TOF/MS analysis
The identification of component peaks was carried out on an ultraperformance liquid chromatography (UPLC) system (Waters, Milford, MA, USA) equipped with a photo-diode array detector. Aliquots 
| Statistical analysis
All quantitative values are presented as means ± standard deviation.
Each experiment was performed in triplicate three to five times. Several figures show results from one representative experiment. Statistical differences were analyzed using Student's t test, and a value of p < 0.05 was considered significant.
3 | RESULTS
| PSWE stimulates BMP-2-induced osteoblast differentiation in C2C12 cells
To study the effect of PSE on BMP-2-mediated osteogenesis, we incubated C2C12 cells with varying concentrations of PSE fractions and then treated them with 100 ng/ml BMP-2. As shown Figure 1 a and Figure S1 , PSWE dramatically induced the expression of ALP in a dose-dependent manner in the presence of BMP-2, whereas the prethanol and hexane fractions of PSE possessed only weak induction activity. Furthermore, PSWE enhanced bone mineralization in MC3T3-E1 and C2C12 cells ( Figure S2 ). However, ALP expression and bone mineralization in MC3T3-E1 cells were not stimulated by PSWE in the absence of BMP-2 ( Figure S3 ). Consistent with this result, PSWE significantly increased BMP-2-stimulated ALP activity in a dose-dependent manner (Figure 1b ). At concentrations up to 100 μg/ml, PSWE and peanut sprout hexane extract (PSHE) did not exhibit any cytotoxicity, whereas peanut sprout prethanol extract (PSPE) inhibited C2C12 cell proliferation at 100 μg/ml (Figure 1c) . Together, these results indicate that PSWE enhances BMP-2-dependent osteogenic differentiation to a greater extent than PSPE or PSHE. these results suggest that the osteogenic activity of PSWE arises from its ability to enhance the expression of Runx2, which is required for osteoblast differentiation. FIGURE 2 Peanut sprout water extract (PSWE) stimulates bone morphogenetic protein-2 (BMP-2)-induced expression of runtrelated transcription factor 2 (Runx2). (a) C2C12 cells were stimulated in the presence of BMP-2 (100 ng/ml) with vehicle (water) or PSWE (100 μg/ml) for the indicated times. mRNA expression levels were assessed using real-time PCR. GAPDH was used as the internal control. * p < 0.05; ** p < 0.01; *** p < 0.001 (versus vehicle control). (b) Effects of PSWE on the levels of Runx2 and alkaline phosphatase were evaluated by immune blot analysis. GAPDH was used as the internal control. One representative result from three independent experiments yielding similar results is shown FIGURE 3 Peanut sprout water extract (PSWE) induces bone morphogenetic protein-2 (BMP-2)-mediated phosphorylation ofAKT/MAP kinase signaling molecules. Following serum starvation for 1 day, C2C12 cells were pretreated with vehicle or PSWE (100 μg/ml) for 1 hr prior to BMP-2 stimulation (100 ng/ml) for the indicated times. The expression levels of the signaling molecules were evaluated by Western blotting. Actin was used as the internal control 3.6 | Soyasaponin Bb content of PSWE and its anabolic activity depend on the germination period
To obtain further insight into how soyasaponin Bb enhanced osteoblast differentiation, we investigated soyasaponin Bb content and the associated effect on anabolic activity, over the course of sprouting. As shown in Figure 6a and Figure S6 , the content of soyasaponin Bb increased remarkably with sprout growth time. At noncytotoxic concentrations (≤30 μg/ml; Figure 6b ), PSWE significantly enhanced BMP-2-stimulated osteogenic differentiation in a manner dependent on sprouting time (Figure 6c ). In addition, ALP activity was further stimulated by increasing the germination period ( Figure 6d ). These results suggest that PSWE by increasing sprouting time could improve osteogenic activity by inducing soyasaponin Bb content. show that PSWE made from sprouts with a longer sprouting period significantly enhanced BMP-2-mediated induction of Runx2, a transcription factor that is required for osteogenic activity.
| DISCUSSION
This study is the first to show that PSWE and soyasaponin Bb PSWE increases BMP-2-dependent osteoblast differentiation by inducing ALP expression and activity without apparent cytotoxicity.
Previous work has shown that BMP-2 promotes the commitment of the pluripotent mesenchymal precursor cell line, C2C12, into preosteoblasts capable of bone formation and mineralization. In addition, the BMP-2-induced commitment of C2C12 cells into osteoblasts leads to ALP expression, an early marker of osteoblastic differentiation.
Furthermore, we found that PSWE dramatically enhanced mRNA and protein expression of Runx2 during BMP-2-dependent osteoblast differentiation, suggesting that PSWE stimulates BMP-2-dependent osteoblast differentiation by inducing osteoblast-specific transcription factors such as Runx2, which is induced during BMP-2-stimulated transdifferentiation of C2C12 cells and involved in the development of osteoblastic cells and bone formation (Wang et al., 2006) . Consistent with this, PSWE treatment also induced the expression of BMP-2-induced Runx2 downstream molecules, such as ALP, OCL, and Col1a, which are known osteoblast-specific molecules (Li, Felber, Elks, Croucher, & Roehl, 2009; Lu, Robertson, & Brennan, 2004) .
The effects of PSWE on osteogenic differentiation enhanced us to investigate BMP-2-related signaling pathways. BMP-2 activates AKT, MAP kinases, and Smad molecules in osteoblastic cells. Interestingly, PSWE treatment did not affect the phosphorylation of AKT and MAP kinases leads to activation of Runx2 (Bokui et al., 2008; Mukherjee, Wilson, & Rotwein, 2010 (Gurfinkel & Rao, 2003; Jiang, Zhong, Qi, & Ma, 1993; Kinjo et al., 2003; Lee, Park, Yeo, Han, & Kim, 2010) . However, its osteogenic activity has not been previously reported. In this study, we showed that soyasaponin Bb in PSWE 
| CONCLUSIONS
To the best of our knowledge, this study is the first to demonstrate that PSWE and its phytochemical soyasaponin Bb have anabolic potential in BMP-2-mediated osteoblast differentiation. Specifically, we found that PSWE and soyasaponin Bb were associated with induction of the MAP kinase-Runx2 signaling pathways required for osteoblast differentiation. Induction of Runx2 leads to the expression of factors required for bone formation, including ALP, OCL, and
Col1a. In addition, the osteogenic activity of PSE is determined by the content of soyasaponin Bb. Although a detailed in vivo experiment and clinical study of the bone formation activity of PSWE should be carried out before it is applied to humans, the results presented here suggest that PSWE and soyasaponin Bb could be useful FIGURE 7 Peanut sprout water extract (PSWE) stimulates runtrelated transcription factor 2 and alkaline phosphatase expression as a function of the length of the germination period. (a) The effect of PSWE on bone morphogenetic protein-2 (BMP-2)-induced mRNA expression was analyzed by real-time PCR as described in Figure 2a . 
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